BHCM
GMED icon

Brevan Howard Capital Management’s Globus Medical GMED Stock Holding History

Brevan Howard Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$359K Sell
4,170
-22,415
-84% -$2.01M ﹤0.01% 1502
2025
Q4 		$2.32M Buy
26,585
+20,922
+369% +$1.59M 0.03% 444
2025
Q3 		$324K Sell
5,663
-3,608
-39% -$208K ﹤0.01% 1529
2025
Q2 		$547K Buy
+9,271
New +$599K ﹤0.01% 1319
2024
Q4 		– Sell
-6,252
Closed -$447K – 1197
2024
Q3 		$447K Sell
6,252
-604
-9% -$42.6K ﹤0.01% 715
2024
Q2 		$470K Buy
+6,856
New +$410K ﹤0.01% 631

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brevan Howard Capital Management's GMED Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Globus Medical (GMED) stake by 84% in Q1 2026, selling an estimated $2.01M and leaving 4,170 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #1502.

Brevan Howard Capital Management first reported a position in GMED in Q2 2024 and has held it in 6 quarters since. The position peaked at $2.32M in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Brevan Howard Capital Management held 4,170 shares of Globus Medical worth $359K as of Q1 2026.
  • Brevan Howard Capital Management sold 22,415 Globus Medical shares in Q1 2026, an estimated $2.01M.
  • Globus Medical made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1502 holding.
  • Brevan Howard Capital Management first reported a position in Globus Medical in Q2 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Globus Medical position peaked at $2.32M in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.